Skip to main content

Amicus Therapeutics Inc. Common Stock (FOLD)

About The Company

FOLD Stock Market Logo

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.

IPO Year Sector Industry
2007 Health Care Biotechnology: Pharmaceutical Preparations

Amicus Therapeutics Inc. (FOLD) Latest News

Company Contact & Address (FOLD)

Corporate Headquarters Phone Website
United States
+1 215 921-7600 Official FOLD Website

FOLD Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ FOLD

Jobs & Employment at Amicus Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Jobs, Employment & Careers at Amicus Therapeutics Inc. (FOLD)

Related & Similar Stock Symbols

CLR Stock Market Price & News


Continental Resources Inc. Common Stock

PSPC Stock Market Price & News


Post Holdings Partnering Corporation Series A Common …

TTCF Stock Market Price & News


Tattooed Chef Inc Class A Common Stock